Affymetrix gets FDA clearance to advertise CytoScan Dx Assay Affymetrix.

We are pleased to have been selected by Affymetrix to become part of the clinical trial for CytoScan Dx Assay and found the performance data of the assay spectacular. With 2-3 % of kids in the United States having some form of developmental delay or intellectual disabilities, finding a analysis for the individual and their family may become a lengthy odyssey. This assay represents the best option for accelerating an accurate diagnosis, said Alka Chaubey, PhD, Director of the Greenwood Genetic Middle's Cytogenetics Laboratory.. Affymetrix gets FDA clearance to advertise CytoScan Dx Assay Affymetrix, Inc. today announced that it provides received 510 clearance from the U.S.The connective tissue around the uterus and the pelvic peritoneum will be attacked by inflammation. And the repeated appearance drives the patients desperate, upset and gloomy and it is the biggest trigger of female infertility also, which means a tragedy for women. Among the conventional therapies at present is surgery. However the surgery can cause permanent damage to women’s reproductive system, especially for those significantly infected but very young and haven’t get married, because the doctor may advise them slicing off fallopian tube.